Cargando…

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

New therapies are an urgent medical need in all breast cancer subgroups. Metabotropic glutamate receptor 1 (mGluR1) is suggested as a potential new molecular target. We examined the prevalence mGluR1 expression in different clinically relevant breast cancer subgroups and determined its association w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastiaansen, Anna E. M., Timmermans, A. Mieke, Smid, Marcel, van Deurzen, Carolien H. M., Hulsenboom, Esther S. P., Prager-van der Smissen, Wendy J. C., Foekens, Renée, Trapman-Jansen, Anita M. A. C., Sillevis Smitt, Peter A. E., Luider, Theo M., Martens, John W. M., vanDuijn, Martijn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749122/ https://www.ncbi.nlm.nih.gov/pubmed/33339858 http://dx.doi.org/10.1038/s41598-020-79248-4

Ejemplares similares

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics
por: VanDuijn, Martijn M., et al.
Publicado: (2017)

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases
por: van den Ende, Nadine S., et al.
Publicado: (2022)

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
por: Liu, Ning Qing, et al.
Publicado: (2016)

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
por: Braakman, René B. H., et al.
Publicado: (2017)

Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients
por: van den Berg, Inge, et al.
Publicado: (2021)

An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
por: Dekker, Lennard J. M., et al.
Publicado: (2010)

Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
por: Liu, Ning Qing, et al.
Publicado: (2014)

Loss of Y-Chromosome during Male Breast Carcinogenesis
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients
por: de Costa, Dominique, et al.
Publicado: (2014)

Carcinoma in situ to invasive breast cancer
por: van Deurzen, Carolien H.M., et al.
Publicado: (2015)

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome
por: de Kruijff, Ingeborg E., et al.
Publicado: (2018)

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
por: Hammerl, Dora, et al.
Publicado: (2021)

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
por: Riaz, Muhammad, et al.
Publicado: (2012)

Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022)

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)

Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration
por: van Coevorden-Hameete, Marleen H., et al.
Publicado: (2015)

P37 MULTIPLE MYELOMA MONITORING FROM ARCHIVED SERUM PROTEIN ELECTROPHORESIS GELS BY MASS SPECTROMETRY AND DE NOVO SEQUENCING
por: Noori, S., et al.
Publicado: (2023)

Using second harmonic generation to predict patient outcome in solid tumors
por: Burke, K., et al.
Publicado: (2015)

A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls
por: Titulaer, Mark K, et al.
Publicado: (2006)

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
por: van den Ende, Nadine S., et al.
Publicado: (2023)

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile
por: Smid, Marcel, et al.
Publicado: (2023)

Understanding drugs in breast cancer through drug sensitivity screening
por: Uhr, Katharina, et al.
Publicado: (2015)

Label-free peptide profiling of Orbitrap™ full mass spectra
por: Titulaer, Mark K, et al.
Publicado: (2011)

Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect
por: Kasten, Chelsea R., et al.
Publicado: (2019)

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
por: van der Noord, Vera E., et al.
Publicado: (2019)

Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells
por: Agahozo, Marie Colombe, et al.
Publicado: (2021)

Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis
por: Noori, Somayya, et al.
Publicado: (2022)

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines
por: Uhr, Katharina, et al.
Publicado: (2019)

P10 AN ULTRA-SENSITIVE METHOD FOR SEQUENCING AND MONITORING OF M-PROTEIN IN PERIPHERAL BLOOD (M-INSIGHT)
por: Bonifay, V., et al.
Publicado: (2023)

B04 IMPLEMENTING M-PROTEIN DIAGNOSTICS IN MULTIPLE MYELOMA PATIENTS USING ULTRA-SENSITIVE TARGETED MASS SPECTROMETRY DATA AND AN OFF-THE-SHELF CALIBRATOR
por: Wijnands, C., et al.
Publicado: (2023)

Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer
por: Sexton, Rachel E., et al.
Publicado: (2018)

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study
por: van Deurzen, Carolien H. M.
Publicado: (2016)

Skin lesions in children admitted to the paediatric intensive care unit: an observational study
por: Sillevis Smitt, J. Henk, et al.
Publicado: (2011)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
por: Van Bockstal, Mieke R., et al.
Publicado: (2019)

Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity
por: Kawakubo, Yuki, et al.
Publicado: (2011)

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment
por: Muñoz-Lopetegi, Amaia, et al.
Publicado: (2020)

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
por: Yu, Jack X, et al.
Publicado: (2007)

Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer
por: Banda, Malathi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7u0btkaqddv2ke0nqhm7gjo1ro